Rosenbluh & colleagues develop SAM-DNMT3A, a tool for inducing genome-wide DNA methylation which revealed that ER+ breast cancer is vulnerable to induction of DNA methylation
https://www.nature.com/articles/s41467-024-54824-8
#NatureCommsBiotech
https://www.nature.com/articles/s41467-024-54824-8
#NatureCommsBiotech
Comments
https://www.nature.com/articles/s41467-024-54781-2
#NatureCommsBiotech
https://www.nature.com/articles/s41467-024-54866-y
#NatureCommsBiotech